European Journal of Medicinal Chemistry p. 383 - 400 (2019)
Update date:2022-08-15
Topics:
Güng?r, Tu?ba
?nder, Ferah C?mert
Tokay, Esra
Gülhan, ünzile Güven
Hac?o?lu, Nelin
Tok, Tu?ba Ta?k?n
?elik, Ayhan
K??kar, Feray
Ay, Mehmet
The use of nitroreductases (NTR) that catalyze the reduction of nitro compounds by using NAD(P)H in GDEPT (Gene-directed enzyme prodrug therapy) studies which minimize toxicity at healthy cells and increases concentration of drugs at cancer cells is remarkable. Discovery of new prodrug/NTR combinations is necessary to be an alternative to known prodrug candidates such as CB1954, SN23862, PR-104A. For this aim, nitro containing aromatic amides (A1-A23) were designed, synthesized, performed in silico ADMET and molecular docking techniques in this study. Prodrug candidates were studied on reduction potentials with Ssap-NtrB by HPLC system. Also, cyototoxic properties and prodrug ability of these amides were investigated using different cancer cell lines such as Hep3B and PC3. As a result of theoretical and biological studies, combinations of A5, A6 and A20 with Ssap-NtrB can be suggested as potential prodrugs/enzyme combinations at NTR based cancer therapy compared with CB1954/NfsB.
View MoreLiao Cheng All Win Chemicals Co.,LTD
Contact:86+0635-2991582
Address:Room 402,Unit 1,No.27 building.Zhong tong shi dai haoyuan,liaocheng city,Shan dong Province.China
WEIFANG RICHEM INTERNATIONAL LTD
Contact:86-536-2222176
Address:weifang,shandong
ZUNYI CITY BEI YUAN CHEMICAL CO., LTD
website:http://www.china-beiyuan.com
Contact:+86-851-27751258
Address:Wujiang Building, Xianggang Road, Zunyi City, Guizhou Province, China
Chemsigma International Co.,Ltd.
website:http://www.chemsigma.com
Contact:86-025-58748998
Address:Rm.705, 15th Building,Rd.Xinke II
suzhou chukai pharmateach co,.ltd
Contact:86-512-88812511
Address:Building 3, Wujiang Scientific Innovation Park, 2358 Changan Rd, Wujiang 215200, Jiangsu Province, P. R. China
Doi:10.1016/j.tetlet.2007.11.065
(2008)Doi:10.1021/jm050050k
(2005)Doi:10.1016/S0020-1693(02)01345-2
(2003)Doi:10.1021/jo00899a014
(1975)Doi:10.1021/ja00544a018
(1980)Doi:10.1002/hlca.200290017
(2002)